Author:
Hong Zhen-Yu,Song Kwang Hyun,Yoon Joo-Heon,Cho Jaeho,Story Michael D.
Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine
Reference42 articles.
1. Videtic GM, Stephans KL (2010) The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient? Curr Oncol Rep 12(4):235–241
2. Timmerman R, Bastasch M, Saha D, Abdulrahman R, Hittson W, Story M (2007) Optimizing dose and fractionation for stereotactic body radiation therapy. Normal tissue and tumor control effects with large dose per fraction. Front Radiat Ther Oncol 40:352–365
3. Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, Ewing M, Abdulrahman R, DesRosiers C, Williams M, Fletcher J (2006) Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24(30):4833–4839
4. Timmerman RD, Story M (2006) Stereotactic body radiation therapy: a treatment in need of basic biological research. Cancer J 12(1):19–20
5. Lo SS, Sahgal A, Kunos AC, Teh SB, Yao M, Machtay M, Mayr AN, Huang Z, Chang LE (2012) Reported Toxicities Associated with Stereotactic Body Radiation Therapy. In: Lo SS, Teh BS, Lu JJ, Schefter TE (eds) Stereotactic Body Radiation Therapy. Springer, Berlin, pp 373–392
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献